Dianne M. Finkelstein
#152,409
Most Influential Person Now
American biostatistician
Dianne M. Finkelstein's AcademicInfluence.com Rankings
Dianne M. Finkelsteinmathematics Degrees
Mathematics
#7042
World Rank
#9649
Historical Rank
#2012
USA Rank
Statistics
#748
World Rank
#836
Historical Rank
#170
USA Rank
Measure Theory
#1816
World Rank
#2222
Historical Rank
#570
USA Rank
Download Badge
Mathematics
Why Is Dianne M. Finkelstein Influential?
(Suggest an Edit or Addition)Dianne M. Finkelstein's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. (1998) (1573)
- Breast cancer in China. (2014) (1109)
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank Tests (2000) (652)
- A proportional hazards model for interval-censored failure time data. (1986) (639)
- Regression of microalbuminuria in type 1 diabetes. (2003) (596)
- Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome. (1988) (459)
- Planning cancer control in Latin America and the Caribbean. (2013) (404)
- Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. (1996) (400)
- Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. (2006) (369)
- A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021. (1992) (348)
- Oncolytic virus therapy of multiple tumors in the brain requires suppression of innate and elicited antiviral responses (1999) (347)
- Heterozygous ATM mutations do not contribute to early onset of breast cancer (1997) (343)
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer. (1986) (331)
- Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. (1989) (330)
- Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. (1986) (320)
- TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. (2015) (320)
- A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection (1995) (316)
- Characterization of BRCA1 and BRCA2 mutations in a large United States sample. (2006) (316)
- A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. (1995) (308)
- Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. (1993) (298)
- Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. (2010) (282)
- Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. (1999) (277)
- Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. (1987) (275)
- Quantitatively determined survivin expression levels are of prognostic value in human gliomas. (2002) (268)
- A semiparametric model for regression analysis of interval-censored failure time data. (1985) (241)
- High risk of breast carcinoma after irradiation of young women with Hodgkin's disease (1997) (227)
- Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer. (1997) (221)
- Brainstem tolerance to conformal radiotherapy of skull base tumors. (1997) (217)
- Combining mortality and longitudinal measures in clinical trials. (1999) (214)
- Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. (2008) (213)
- Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. (1993) (212)
- Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. (1996) (210)
- Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. (2005) (207)
- Multimodality management of Merkel cell carcinoma. (1999) (205)
- Computer-based interview for screening blood donors for risk of HIV transmission. (1990) (200)
- Superiority of quantitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: a comparison with cardiac catheterization. (1988) (190)
- Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine (1996) (189)
- Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study. (1995) (181)
- Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker (2013) (178)
- Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma. (1999) (170)
- Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. (2001) (164)
- Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. (2010) (157)
- Breast cancer in Brazil: present status and future goals. (2012) (152)
- Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. (2000) (151)
- Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas. (1996) (141)
- Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. (2003) (140)
- Design considerations for AIDS trials. (1990) (134)
- Comparing survival of a sample to that of a standard population. (2003) (133)
- Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. (1995) (129)
- Predictors of skeletal complications in patients with metastatic breast carcinoma (2000) (128)
- Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. (2013) (127)
- Breast cancer in Mexico: a growing challenge to health and the health system. (2012) (122)
- Delayed Central Nervous System Myelination in the Sudden Infant Death Syndrome (1991) (119)
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. (2019) (118)
- Prevention of coronary artery reocclusion and reduction in late coronary artery stenosis after thrombolytic therapy in patients with acute myocardial infarction. A randomized study of maintenance infusion of recombinant human tissue-type plasminogen activator. (1988) (116)
- Vaccination for experimental gliomas using GM-CSF-transduced glioma cells. (1997) (115)
- Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. (2000) (107)
- Chemotherapy for metastatic non-small-cell bronchogenic carcinoma: EST 2575, generation V--a randomized comparison of four cisplatin-containing regimens. (1985) (107)
- Correlation between template bleeding times and spontaneous bleeding during treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator. (1989) (107)
- A Pilot Study of the Functional Living Index‐Cancer (FLIC) Scale for the Assessment of Quality of Life for Metastatic Lung Cancer Patients: An Eastern Cooperative Oncology Group Study (1988) (105)
- Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. (2000) (104)
- Temporal lobe (TL) damage following surgery and high-dose photon and proton irradiation in 96 patients affected by chordomas and chondrosarcomas of the base of the skull. (1998) (104)
- Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. (2005) (103)
- Decreased serotonin function in bulimia nervosa. (1997) (102)
- Detection of coronary artery reperfusion with creatine kinase-MB determinations during thrombolytic therapy: correlation with acute angiography. (1988) (99)
- A Proportional Hazards Model for Multivariate Interval‐Censored Failure Time Data (2000) (99)
- Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. (2015) (99)
- A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group. (1990) (97)
- Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk – Combined Results from Two Screening Trials (2017) (95)
- Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. (2001) (87)
- Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. (2000) (86)
- Phase II Study of Paclitaxel and Carboplatin for Malignant Melanoma (2002) (86)
- Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? (2013) (84)
- Outcomes of Breast Cancer in Brazil Related to Health Care Coverage: A Retrospective Cohort Study (2013) (84)
- A Markov chain Monte Carlo EM algorithm for analyzing interval-censored data under the Cox proportional hazards model. (1998) (82)
- Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector (1998) (81)
- Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. (2000) (78)
- Increased Prevalence of EGFR-Mutant Lung Cancer in Women and in East Asian Populations: Analysis of Estrogen-Related Polymorphisms (2008) (70)
- A non-parametric maximum likelihood estimator for bivariate interval censored data. (1999) (68)
- Bayesian design using adult data to augment pediatric trials (2009) (67)
- Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. (2014) (66)
- Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer (2010) (66)
- Predicting time to prostate cancer recurrence based on joint models for non‐linear longitudinal biomarkers and event time outcomes (2002) (64)
- Adjuvant denosumab in early breast cancer: First results from the international multicenter randomized phase III placebo controlled D-CARE study. (2018) (63)
- Validity of Models for Predicting BRCA1 and BRCA2 Mutations (2007) (63)
- Patterns of opportunistic infections in patients with HIV infection. (1996) (61)
- Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. (1995) (60)
- Evidence for an association between cutaneous melanoma and non‐Hodgkin lymphoma (2001) (59)
- Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. (2007) (59)
- The Cancer Genetics Network: Recruitment Results and Pilot Studies (2003) (58)
- Large Prospective Study of Ovarian Cancer Screening in High-Risk Women: CA125 Cut-Point Defined by Menopausal Status (2011) (57)
- Analysis of Failure Time Data with Dependent Interval Censoring (2002) (54)
- Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. (2007) (53)
- Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. (2008) (51)
- A Randomized Trial to Increase Colonoscopy Screening in Members of High-Risk Families in the Colorectal Cancer Family Registry and Cancer Genetics Network (2014) (51)
- Determinants of accrual of women to a large, multicenter clinical trials program of human immunodeficiency virus infection. The AIDS Clinical Trials Group. (1993) (47)
- Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. (2000) (47)
- Fine‐needle aspiration cytology of the breast: Invasive vs. in situ carcinoma (2001) (46)
- Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. (2002) (46)
- A proportional hazards model for truncated AIDS data. (1993) (45)
- Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS: AIDS Clinical Trials Group 044. (1994) (45)
- The clinical significance of variant-morphology small-cell carcinoma of the lung. (1990) (44)
- Regression analysis of failure time data with informative interval censoring (2007) (44)
- A Phase II Study of Recombinant Human Interferon-α2a and Zidovudine in Patients with AIDS-Related Kaposi's Sarcoma (1996) (44)
- Quantitation of acute myocardial infarct size by nuclear magnetic resonance imaging. (1990) (43)
- A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. (1995) (42)
- Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. (1989) (42)
- Clinically relevant changes in family history of cancer over time. (2011) (41)
- Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. (2009) (41)
- Analysis of Failure and Survival Data (2002) (40)
- AIDS clinical trials (1995) (40)
- Justification for evaluating new anticancer drugs in selected untreated patients with extensive-stage small-cell lung cancer: an Eastern Cooperative Oncology Group randomized study. (1992) (40)
- Statistical issues arising in AIDS clinical trials (1992) (39)
- Meta-analysis of survey data: application to health services research (2008) (39)
- Serotonin Function Following Remission from Bulimia Nervosa (2000) (38)
- A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l (2001) (36)
- Analysing survival in the presence of an auxiliary variable. (1994) (36)
- Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis (2010) (36)
- Analysis of MHC class II DP, DQ and DR alleles in Crohn’s disease (1998) (36)
- Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? (2012) (34)
- Applying the Cox Proportional Hazards Model When the Change Time of a Binary Time‐Varying Covariate Is Interval Censored (1999) (34)
- Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. (2015) (34)
- Global rank tests for multiple, possibly censored, outcomes (2016) (32)
- Model‐based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center (2002) (32)
- Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. (2000) (32)
- TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. (2011) (32)
- Bleeding time prolongation and bleeding during infusion of recombinant tissue-type plasminogen activator in dogs: potentiation by aspirin and reversal with aprotinin. (1991) (30)
- Computer interview for screening blood donors for risk of HIV transmission. (1994) (30)
- Immediate reproducibility of electrically induced sustained monomorphic ventricular tachycardia before and during antiarrhythmic therapy. (1991) (29)
- Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer. (2017) (28)
- Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy (2015) (28)
- Long-term risk of medical conditions associated with breast cancer treatment (2014) (27)
- Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project (2016) (27)
- Strategies for developing biostatistics resources in an academic health center. (2013) (27)
- Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis (2018) (26)
- A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors (2000) (26)
- Analysis of multiple failure time data from an AIDS clinical trial. (1997) (25)
- Myocardial uptake and clearance of thallium-201 in normal subjects: comparison of dipyridamole-induced hyperemia with exercise stress. (1987) (25)
- Dose-volume tolerance of the brainstem after high-dose radiotherapy. (1999) (25)
- Early assessment of the effect of map-guided transcatheter intracardiac electric shock on sustained ventricular tachycardia secondary to coronary artery disease. (1988) (25)
- An extension of Kendall's coefficient of concordance to bivariate interval censored data. (1999) (24)
- Graphing the Win Ratio and its components over time (2018) (23)
- Predictors of automatic implantable cardioverter defibrillator discharge for life-threatening ventricular arrhythmias. (1988) (23)
- Applying the Cox proportional hazards model for analysis of latency data with interval censoring. (1999) (23)
- Estimating Carcinogenic Potency from a Rodent Tumorigenicity Experiment (1987) (22)
- Issues in the design of drug trials for AIDS. (1990) (22)
- Analysis of multiple tumor data from a rodent carcinogenicity experiment. (1989) (22)
- Analysis of familial aggregation studies with complex ascertainment schemes (2008) (21)
- Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis (2014) (18)
- Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). (2002) (18)
- Phase II Trial of Acivicin Versus Etoposide‐Cisplatin in Non‐Small Cell Lung Cancer: An Eastern Cooperative Oncology Group Study (1994) (18)
- Testing for Dependence Between Failure Time and Visit Compliance with Interval‐Censored Data (2002) (17)
- Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma (2014) (17)
- Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination (2021) (16)
- Identification and Interpretation of Longitudinal Gene Expression Changes in Trauma (2010) (16)
- A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer. (1999) (16)
- The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. (2012) (15)
- 2064 Optic neuropathy following combined proton and photon radiotherapy for base of skull tumors (1997) (15)
- Identification of biomarkers to predict response to single-agent platinum chemotherapy in metastatic triple-negative breast cancer (mTNBC): Correlative studies from TBCRC009. (2014) (15)
- Physical and psychological health in rare cancer survivors (2017) (15)
- Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method. (2011) (15)
- Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung cancer (EST 3583): an Eastern Cooperative Oncology Group study. (1989) (14)
- Access to care issues adversely affect breast cancer patients in Mexico: oncologists’ perspective (2014) (14)
- A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE). (2011) (12)
- Design considerations in a sib-pair study of linkage for susceptibility loci in cancer (2008) (11)
- Physical symptoms in long-term survivors of rare cancer (2018) (11)
- A Reliable Method of Demonstrating HER-2/ neu, Estrogen Receptors, and Progesterone Receptors on Routinely Processed Cytologic Material (2001) (11)
- Isotontic regression for interval censored survival data using an e-m algorithm (1986) (11)
- Analysis of familial aggregation in the presence of varying family sizes (2005) (10)
- Biologically relevant 3D tumor arrays: treatment response and the importance of stromal partners (2011) (10)
- Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011. (2017) (10)
- Survival analysis of longitudinal microarrays (2006) (10)
- Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. (2015) (10)
- High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors. (2017) (10)
- Design and analysis of a clinical trial using previous trials as historical control (2019) (10)
- Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma (2005) (10)
- Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy (2014) (9)
- Clinical Grade “SNaPshot” Genetic Mutation Profiling in Multiple Myeloma (2014) (9)
- Abstract PD09-03: Impact of BRCA1/2 Mutation Status in TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple negative breast cancer. (2012) (9)
- SECOND MALIGNANCIES IN HODGKIN’S DISEASE (2000) (9)
- Modelling the relationship between continuous covariates and clinical events using isotonic regression (2003) (9)
- S4-7: Results of a Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib in Women with Early-Stage ErbB2-Overexpressing Breast Cancer. (2011) (8)
- Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study. (1985) (7)
- Modeling the effect of dose on the lifetime tumor rate from an animal carcinogenicity experiment. (1991) (7)
- Designing phase II studies of chemotherapy for HIV infection using CD4 as an end-point. (1993) (7)
- Outcome-Driven Cluster Analysis with Application to Microarray Data (2015) (7)
- A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder (2019) (6)
- A Score Test for Association of a Longitudinal Marker and an Event with Missing Data (2010) (6)
- Analysis of the relationship between longitudinal gene expressions and ordered categorical event data (2009) (6)
- A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC). (2011) (6)
- Studying treatments for AIDS: new challenges for clinical trials--a panel discussion at the 1990 annual meeting of the Society for Clinical Trials. (1992) (6)
- Web-browser encryption of personal health information (2011) (6)
- Survivors of Out-of-Hospital Cardiac Arrest (2005) (5)
- A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group. (1996) (5)
- Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study. (1985) (5)
- Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, placebo-controlled, randomized, double-blind phase III clinical trial. (2013) (5)
- A prospective multi-center ovarian cancer screening study in women at increased risk (2007) (5)
- A joint test for progression and survival with interval‐censored data from a cancer clinical trial (2014) (5)
- Analysis of Co-Aggregation of Cancer Based on Registry Data (2006) (5)
- 2066 Radiation tolerance of the cervical spinal cord: Incidence and dose-volume relationship of symptomatic and asymptomatic late effects following high dose irradiation of paraspinal tumors (1997) (4)
- Assessing survival benefit when treatment delays disease progression (2016) (4)
- Multivariate logistic regression for familial aggregation in age at disease onset (2007) (4)
- Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. (2016) (4)
- Guidelines for the design and conduct of AIDS clinical trials. AIDS Clinical Trials Group. (1993) (4)
- Methodological issues in AIDS clinical trials (1992) (3)
- A test for the relationship between a time‐varying marker and both recovery and progression with missing data (2011) (3)
- Comparison of Oral Agents for Treatment of Pneumocystis carinii Pneumonia (1997) (3)
- Are rare cancer survivors at elevated risk of subsequent new cancers? (2019) (3)
- 7 q 31 : A Genome-Wide Analysis Common Familial Colorectal Cancer Linked to Chromosome (2008) (2)
- Prevalence of hepatitis B serologic markers in community hospital personnel. (1987) (2)
- A model‐informed rank test for right‐censored data with intermediate states (2015) (2)
- Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancer (1990) (2)
- Imaging enabled platforms for development of therapeutics (2011) (2)
- Denosumab Versus Placebo as Adjuvant Treatment for Women With Early-Stage Breast Cancer at High Risk of Disease Recurrence (D-CARE): An in Progress, Phase 3 Clinical Trial (2012) (2)
- Adjuvant lapatinib in women with early-stage HER2-positive breast cancer (HER2+ BC): Analysis of the hormone receptor-negative subgroup of the intent-to-treat (ITT) population of the TEACH trial. (2012) (2)
- Lack of efficacy of adjuvant lapatinib in HER2-negative breast cancer (HER2–ve BC): Analysis of patients in the TEACH trial. (2013) (2)
- Abstract OT2-6-02: Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): A global, placebo-controlled, randomized, double-blind, phase 3 clinical trial (2013) (2)
- Abstract OT2-3-03: Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase 3 clinical trial (2012) (2)
- Denosumab versus placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE): An international, randomized, double-blind, placebo-controlled phase III clinical trial. (2012) (1)
- Prospective multicenter ovarian cancer screening trial of women at high risk: Preliminary results from the first 2,200 women. (2002) (1)
- Clinical grade SNaPshot genetic mutation profiling in multiple myeloma. (2014) (1)
- Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort. (2011) (1)
- Prevention of bacterial infection in AIDS: A randomized trial of three agents (1997) (1)
- Statistical Issues Arising in AIDS Clinical Trials: Rejoinder (1992) (1)
- P1-12-26: Global Patterns of Care for HER2/Neu Overexpressing Breast Cancer. (2011) (1)
- P1-11-12: Patterns of Care of Newly Diagnosed Patients with Breast Cancer in Mexico. (2011) (1)
- Frequency and impact of tumor genotyping in clinical practice of patients with advanced biliary tract cancers (ABTCs). (2017) (1)
- Awareness and uptake of genetic testing among individuals at-risk for hereditary colon cancer (2011) (1)
- Estimation for an accelerated failure time model with intermediate states as auxiliary information (2018) (1)
- A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. (2011) (1)
- OT1-01-03: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Multicenter Study Comparing Denosumab with Placebo as Adjuvant Treatment for Women with Early-Stage Breast Cancer Who Are at High Risk of Disease Recurrence (D-CARE). (2011) (1)
- 102 Hypothalamic-pituitary gland dysfunction following high dose conformal mixed proton/photon radiotherapy to the base of skull region: demonstration of a dose effect relationship using dose volume histogram analysis (1999) (1)
- 967 Main-Duct and Combined IPMNs Are the Same Clinical Entity and Distinct from Branch-Duct IPMNs (2009) (1)
- Access to care issues adversely affect breast cancer patients in Mexico: oncologists’ perspective (2014) (1)
- Usefulness of collecting individual data in meta-analyses (1991) (0)
- Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy (2015) (0)
- Breast Cancer After Supradiaphragmatic Irradiation for Hodgkin's Disease; Risk Analysis and Possible Surveillance Strategies (2007) (0)
- Long-term aerosol pentamidine prophylaxis and pulmonary function (1997) (0)
- A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma (2005) (0)
- Late effects in rare cancer registrants. (2014) (0)
- TEACH phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-overexpressing breast cancer (2008) (0)
- Lapatinib in HER2+ early breast cancer: Quality of life analysis. (2012) (0)
- Informatively clustering longitudinal microarrays using binary or survival outcome data (2018) (0)
- P1-08-17: Pregnancy-Associated Breast Cancer Does Not Have a Worse Outcome in the 4912 Women with Breast Cancer of the AMAZONA Project. (2011) (0)
- Comparing treatment strategies using a synthesized clinical trial: an analysis of late versus early use of trimethoprim-sulfamethoxazole for AIDS patients (2001) (0)
- LISA CHASAN-TABER. Writing Dissertation and Grant Proposals: Epidemiology, Preventive Medicine and Biostatistics. Boca Raton: CRC Press (2017) (0)
- Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation (2022) (0)
- Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. (2011) (0)
- Prevalence ofHepatitis B Serologic Markers inCommunityHospital Personnel (1987) (0)
- Irinotecan , in Combination with Cyclophosphamide Carboxylesterase Secreted Human Intestinal and CYP 2 B 1 Genes , Simplex Virus Type 1 Expressing the Prodrug-Activating Brain Tumor Oncolysis with Replication-Conditional Herpes (2005) (0)
- Reocclusion and Reduction in Late Coronary Artery Stenosis After Thrombolytic Therapy (2005) (0)
- 141 Thymosin B15 staining predicts for distant failure in patients with prostate cancer who are clinically M0 at presentation (1999) (0)
- Abstract P4-02-01: Normalization of compression-induced hemodynamics in patients responding to neoadjuvant chemotherapy using dynamic tomographic optical breast imaging (TOBI) (2013) (0)
- Data Monitoring in the AIDS Clinical Trials Group Study #981: Conflicting Interim Results (2006) (0)
- Cancer esearch apeutics , Targets , and Chemical Biology ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian (2010) (0)
- ergistic Enhancement of Carboplatin Efficacy with todynamic Therapy in a Three-Dimensional Model for R rometastatic Ovarian Cancer (2010) (0)
- Mechanism-based enhancement of molecular, cellular and stromal therapies by PDT in a 3D model for micrometastatic ovarian cancer (2011) (0)
- T1101 Screening Behavior, and Attitudes and Beliefs About Colon Cancer Screening in a High-Risk Population: Baseline Data from the Family Health Promotion Project (FHPP) (2008) (0)
- 229 Outcome Analysis of the Family Health Promotion Project: An Intervention to Improve Colonoscopy Screening Compliance in Families at High Risk of Colorectal Cancer (2010) (0)
- Are rare cancer survivors at elevated risk of subsequent new cancers? (2019) (0)
- Clinical Trial Prevention of Coronary Artery Reocclusion and Reduction in Late Coronary Artery Stenosis After Thrombolytic Therapy in Patients With Acute Myocardial Infarction A Randomized Study of Maintenance Infusion of Recombinant Human Tissue-Type Plasminogen Activator (2005) (0)
- Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. (2011) (0)
- Gene expression Survival analysis of longitudinal microarrays (2006) (0)
- Abstract P3-06-27: Dynamic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer (2012) (0)
- Stage I bronchioloalveolar carcinoma: Results of surgical treatment (2000) (0)
- Abstract P3-10-26: Quantitative Protein and Gene Expression Biomarkers of Tamoxifen and Letrozole Recurrence in the NCIC CTG MA.17 Cohort (2010) (0)
- Estimation for an accelerated failure time model with intermediate states as auxiliary information (2018) (0)
- OP05.06: Immediate postpartum access to cardiac therapy: outcomes of a coordinated strategy for managing the fetus with severe cardiovascular disease (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Dianne M. Finkelstein?
Dianne M. Finkelstein is affiliated with the following schools:
